Literature DB >> 12520178

Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans.

Miao-Ying Lai1, Su-Lan Hsiu, Chung-Chuan Chen, Yu-Chi Hou, Pei-Dawn Lee Chao.   

Abstract

Baicalin, baicalein, wogonoside and wogonin are flavone constituents of Scutellariae Radix with various beneficial biological activities. The purpose of this study was to investigate the urinary pharmacokinetics of these flavones after oral administration of Scutellariae Radix commercial powder. Ten healthy male volunteers received a dose of 5.2 g commercial powder (comparable to 9 g crude drug), respectively. The concentrations of baicalin, baicalein and wogonin in the commercial powder as well as their metabolites in urine were assayed by HPLC method. The glucuronides and sulfates of baicalein and wogonin in urine were hydrolyzed with beta-glucuronidase and sulfatase, respectively. Our results showed that the mean cumulated renal excretion of baicalein glucuronides and sulfates were 43.1+/-4.5 micromol (2.9% of dose) and 64.8+/-6.3 micromol (4.3% of dose), respectively, whereas wogonin glucuronides and sulfates were 21.6+/-2.0 micromol (5.9% of dose) and 20.7+/-1.7 micromol (5.7% of dose), respectively. The result indicated that the renal excretion of conjugated metabolites of wogonin (11.6% of dose) were higher than that of baicalein (7.2% of dose). The baicalein sulfates was predominant than the corresponding glucuronides, whereas wogonin sulfates was comparable to the corresponding glucuronides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520178     DOI: 10.1248/bpb.26.79

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  28 in total

1.  Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.

Authors:  Xiuqiong He; Lixia Pei; Henry H Y Tong; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Role of intestinal first-pass metabolism of baicalein in its absorption process.

Authors:  Li Zhang; Ge Lin; Qi Chang; Zhong Zuo
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

3.  Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.

Authors:  J M Huang; W Y Weng; X B Huang; Y H Ji; E Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

4.  Hepatic metabolism and disposition of baicalein via the coupling of conjugation enzymes and transporters-in vitro and in vivo evidences.

Authors:  Li Zhang; Chenrui Li; Ge Lin; Peter Krajcsi; Zhong Zuo
Journal:  AAPS J       Date:  2011-05-24       Impact factor: 4.009

5.  Baicalin increases VEGF expression and angiogenesis by activating the ERR{alpha}/PGC-1{alpha} pathway.

Authors:  Keqiang Zhang; Jianming Lu; Taisuke Mori; Leslie Smith-Powell; Timothy W Synold; Shiuan Chen; Wei Wen
Journal:  Cardiovasc Res       Date:  2010-09-16       Impact factor: 10.787

Review 6.  Herb-drug interactions: a literature review.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi Lui Ho; Sui Yung Chan; Paul Wan Sia Heng; Eli Chan; Wei Duan; Hwee Ling Koh; Shufeng Zhou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes.

Authors:  Qiong Zhou; Zhijie Zheng; Bijun Xia; Lan Tang; Chang Lv; Wei Liu; Zhongqiu Liu; Ming Hu
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

8.  Baicalein protects mice against radiation-induced DNA damages and genotoxicity.

Authors:  Nitin Motilal Gandhi
Journal:  Mol Cell Biochem       Date:  2013-04-20       Impact factor: 3.396

9.  Iron-binding and anti-Fenton properties of baicalein and baicalin.

Authors:  Carlos A Perez; Yibin Wei; Maolin Guo
Journal:  J Inorg Biochem       Date:  2008-11-19       Impact factor: 4.155

10.  Pharmacokinetics and Relative Bioavailability of Flavonoids between Two Dosage Forms of Gegen-Qinlian-Tang in Rats.

Authors:  Chung-Ping Yu; Chi-Sheng Shia; Shang-Yuan Tsai; Yu-Chi Hou
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.